8-144051491-GC-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The ENST00000618853.5(OPLAH):c.3721-20del variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.031 ( 585 hom., cov: 12)
Exomes 𝑓: 0.0026 ( 200 hom. )
Consequence
OPLAH
ENST00000618853.5 intron
ENST00000618853.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -3.48
Genes affected
OPLAH (HGNC:8149): (5-oxoprolinase, ATP-hydrolysing) The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD). [provided by RefSeq, Jun 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 8-144051491-GC-G is Benign according to our data. Variant chr8-144051491-GC-G is described in ClinVar as [Benign]. Clinvar id is 1169394.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPLAH | NM_017570.5 | c.3721-20del | intron_variant | ENST00000618853.5 | NP_060040.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPLAH | ENST00000618853.5 | c.3721-20del | intron_variant | 1 | NM_017570.5 | ENSP00000480476 | P1 | |||
ENST00000528912.1 | n.1360del | non_coding_transcript_exon_variant | 5/5 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0313 AC: 4357AN: 139156Hom.: 585 Cov.: 12
GnomAD3 genomes
AF:
AC:
4357
AN:
139156
Hom.:
Cov.:
12
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00208 AC: 247AN: 118788Hom.: 14 AF XY: 0.00168 AC XY: 112AN XY: 66660
GnomAD3 exomes
AF:
AC:
247
AN:
118788
Hom.:
AF XY:
AC XY:
112
AN XY:
66660
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00263 AC: 3271AN: 1241924Hom.: 200 Cov.: 10 AF XY: 0.00236 AC XY: 1445AN XY: 611582
GnomAD4 exome
AF:
AC:
3271
AN:
1241924
Hom.:
Cov.:
10
AF XY:
AC XY:
1445
AN XY:
611582
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0313 AC: 4364AN: 139218Hom.: 585 Cov.: 12 AF XY: 0.0309 AC XY: 2107AN XY: 68264
GnomAD4 genome
AF:
AC:
4364
AN:
139218
Hom.:
Cov.:
12
AF XY:
AC XY:
2107
AN XY:
68264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
5-Oxoprolinase deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 22, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at